Your browser doesn't support javascript.
loading
Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
Fry, Norman K; Litt, David J; Duncan, John; Vaghji, Lalita; Warrener, Lenesha; Samuel, Dhanraj; Andrews, Nick; Harnden, Anthony; Harrison, Timothy G.
Afiliação
  • Fry NK; Public Health England-Respiratory and Vaccine Preventable Bacteria Reference Unit, Colindale, London, UK.
  • Litt DJ; Public Health England-Respiratory and Vaccine Preventable Bacteria Reference Unit, Colindale, London, UK.
  • Duncan J; Public Health England-Respiratory and Vaccine Preventable Bacteria Reference Unit, Colindale, London, UK.
  • Vaghji L; Public Health England-Respiratory and Vaccine Preventable Bacteria Reference Unit, Colindale, London, UK.
  • Warrener L; Public Health England-Virus Reference Department, Colindale, London, UK.
  • Samuel D; Public Health England-Virus Reference Department, Colindale, London, UK.
  • Andrews N; Public Health England-Statistics, Modelling and Economics Department, Health Protection Services, Colindale, London, UK.
  • Harnden A; University of Oxford, Department of Primary Care Health Sciences, Oxford, UK.
  • Harrison TG; Public Health England-Respiratory and Vaccine Preventable Bacteria Reference Unit, Colindale, London, UK.
J Med Microbiol ; 62(Pt 9): 1281-1289, 2013 Sep.
Article em En | MEDLINE | ID: mdl-23722435
ABSTRACT
Recent vaccination with pertussis vaccine can confound serological and oral fluid (OF) assays targeting anti-pertussis toxin (anti-PT) IgG antibodies as a marker of recent infection. This study sought to establish the minimum potentially confounding time period based on experimental data to assist interpretation from such samples submitted from UK subjects for pertussis diagnosis. Anti-PT IgG antibody response and decay were measured post-vaccination using a modified OF IgG antibody-capture ELISA (GACELISA). Data were obtained from 72 infants after the third acellular pertussis vaccine dose in the primary schedule (4 months of age) and from 119 children after the single dose at preschool age (3 years 4 months to 5 years 8 months of age). Specimens were taken at approximately 1 month intervals for 9 months post-primary immunization (third dose) and 13 months post-preschool booster (PSB). The modified GACELISA demonstrated a sensitivity of 52/56 (92.9 % 95 % CI 82.7-98.0) and a specificity of 120/128 (93.8 % 95 % CI 88.0-97.3) and showed good agreement with the National Reference Laboratory standard anti-PT IgG serum ELISA (rank correlation = 0.80) and the original OF assay (rank correlation = 0.79). Modelling of the decline in antibody titres showed a reduction of 54 % and 34 % for each doubling of time after day 14 for the post-third primary dose and post-PSB subjects, respectively. These data suggest that the minimum confounding time period is approximately 300 days for samples obtained post-primary immunization and at least 3 years for samples submitted from UK children following immunization with the PSB. These data will greatly assist the interpretation of single high diagnostic anti-PT IgG titres by allowing an estimate of the positive predictive value, when the number of days post-immunization and prevalence are known or assumed.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Vacina contra Coqueluche / Vacinas Acelulares / Toxina Pertussis / Anticorpos Antibacterianos Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Child, preschool / Humans / Infant País/Região como assunto: Europa Idioma: En Revista: J Med Microbiol Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoglobulina G / Vacina contra Coqueluche / Vacinas Acelulares / Toxina Pertussis / Anticorpos Antibacterianos Tipo de estudo: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Child, preschool / Humans / Infant País/Região como assunto: Europa Idioma: En Revista: J Med Microbiol Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Reino Unido